Literature DB >> 26877236

The Oct1 transcription factor and epithelial malignancies: Old protein learns new tricks.

Karina Vázquez-Arreguín1, Dean Tantin2.   

Abstract

The metazoan-specific POU domain transcription factor family comprises activities underpinning developmental processes such as embryonic pluripotency and neuronal specification. Some POU family proteins efficiently bind an 8-bp DNA element known as the octamer motif. These proteins are known as Oct transcription factors. Oct1/POU2F1 is the only widely expressed POU factor. Unlike other POU factors it controls no specific developmental or organ system. Oct1 was originally described to operate at target genes associated with proliferation and immune modulation, but more recent results additionally identify targets associated with oxidative and cytotoxic stress resistance, metabolic regulation, stem cell function and other unexpected processes. Oct1 is pro-oncogenic in multiple contexts, and several recent reports provide broad evidence that Oct1 has prognostic and therapeutic value in multiple epithelial tumor settings. This review focuses on established and emerging roles of Oct1 in epithelial tumors, with an emphasis on mechanisms of transcription regulation by Oct1 that may underpin these findings. This article is part of a Special Issue entitled: The Oct Transcription Factor Family, edited by Dr. Dean Tantin.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Breast cancer; Cervical cancer; Colorectal cancer; Gastric cancer; Jmjd1a/KDM3A; Lung adenocarcinoma; NuRD; Oct1/POU2F1; Prostate cancer; Thyroid cancer

Mesh:

Substances:

Year:  2016        PMID: 26877236      PMCID: PMC4880489          DOI: 10.1016/j.bbagrm.2016.02.007

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  136 in total

1.  Oct1 loss of function induces a coordinate metabolic shift that opposes tumorigenicity.

Authors:  Arvind Shakya; Robert Cooksey; James E Cox; Victoria Wang; Donald A McClain; Dean Tantin
Journal:  Nat Cell Biol       Date:  2009-02-15       Impact factor: 28.824

2.  OCT-1 is over-expressed in intestinal metaplasia and intestinal gastric carcinomas and binds to, but does not transactivate, CDX2 in gastric cells.

Authors:  Raquel Almeida; José Almeida; Michal Shoshkes; Nuno Mendes; Patrícia Mesquita; Elisabete Silva; Isabelle Van Seuningen; Celso A Reis; Filipe Santos-Silva; Leonor David
Journal:  J Pathol       Date:  2005-12       Impact factor: 7.996

3.  Selective binding of steroid hormone receptors to octamer transcription factors determines transcriptional synergism at the mouse mammary tumor virus promoter.

Authors:  G G Préfontaine; R Walther; W Giffin; M E Lemieux; L Pope; R J Haché
Journal:  J Biol Chem       Date:  1999-09-17       Impact factor: 5.157

4.  POU homeodomain protein Oct-1 functions as a sensor for cyclic AMP.

Authors:  Peixiang Wang; Qinghua Wang; Jane Sun; Jing Wu; Hang Li; Nina Zhang; Yachi Huang; Brenda Su; Ren-ke Li; Ling Liu; Yi Zhang; Harry P Elsholtz; Jim Hu; Herbert Y Gaisano; Tianru Jin
Journal:  J Biol Chem       Date:  2009-07-18       Impact factor: 5.157

5.  Embryonic lethality, decreased erythropoiesis, and defective octamer-dependent promoter activation in Oct-1-deficient mice.

Authors:  Victoria E H Wang; Tara Schmidt; Jianzhu Chen; Phillip A Sharp; Dean Tantin
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

6.  Stromal gene expression predicts clinical outcome in breast cancer.

Authors:  Greg Finak; Nicholas Bertos; Francois Pepin; Svetlana Sadekova; Margarita Souleimanova; Hong Zhao; Haiying Chen; Gulbeyaz Omeroglu; Sarkis Meterissian; Atilla Omeroglu; Michael Hallett; Morag Park
Journal:  Nat Med       Date:  2008-04-27       Impact factor: 53.440

7.  Transcriptional coexpression network reveals the involvement of varying stem cell features with different dysregulations in different gastric cancer subtypes.

Authors:  Kalaivani Kalamohan; Jayaprakash Periasamy; Divya Bhaskar Rao; Georgina D Barnabas; Srigayatri Ponnaiyan; Kumaresan Ganesan
Journal:  Mol Oncol       Date:  2014-05-09       Impact factor: 6.603

8.  In vivo and in vitro expression of octamer binding proteins in human melanoma metastases, brain tissue, and fibroblasts.

Authors:  J A Thomson; P G Parsons; R A Sturm
Journal:  Pigment Cell Res       Date:  1993-02

9.  COSMIC: exploring the world's knowledge of somatic mutations in human cancer.

Authors:  Simon A Forbes; David Beare; Prasad Gunasekaran; Kenric Leung; Nidhi Bindal; Harry Boutselakis; Minjie Ding; Sally Bamford; Charlotte Cole; Sari Ward; Chai Yin Kok; Mingming Jia; Tisham De; Jon W Teague; Michael R Stratton; Ultan McDermott; Peter J Campbell
Journal:  Nucleic Acids Res       Date:  2014-10-29       Impact factor: 16.971

10.  POU2F1 activity regulates HOXD10 and HOXD11 promoting a proliferative and invasive phenotype in head and neck cancer.

Authors:  Daniel J Sharpe; Katy S Orr; Michael Moran; Sharon J White; Stephen McQuaid; Terence R Lappin; Alexander Thompson; Jacqueline A James
Journal:  Oncotarget       Date:  2014-09-30
View more
  29 in total

1.  Octamer transcription factor-1 induces the Warburg effect via up-regulation of hexokinase 2 in non-small cell lung cancer.

Authors:  Zhen Li; Jin Su; Mingming Sun; Jiaqi Song; Huanran Sun; Jun Fan; Guo Chen; Changliang Shan; Qi Qi; Shuai Zhang
Journal:  Mol Cell Biochem       Date:  2021-05-10       Impact factor: 3.396

2.  Collective invasion of glioma cells through OCT1 signalling and interaction with reactive astrocytes after surgery.

Authors:  Yangjin Kim; Donggu Lee; Sean Lawler
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2020-07-27       Impact factor: 6.237

3.  A human cell atlas of fetal chromatin accessibility.

Authors:  Silvia Domcke; Andrew J Hill; Riza M Daza; Junyue Cao; Diana R O'Day; Hannah A Pliner; Kimberly A Aldinger; Dmitry Pokholok; Fan Zhang; Jennifer H Milbank; Michael A Zager; Ian A Glass; Frank J Steemers; Dan Doherty; Cole Trapnell; Darren A Cusanovich; Jay Shendure
Journal:  Science       Date:  2020-11-13       Impact factor: 47.728

Review 4.  The BRCA1/BARD1 ubiquitin ligase and its substrates.

Authors:  Samuel R Witus; Mikaela D Stewart; Rachel E Klevit
Journal:  Biochem J       Date:  2021-09-30       Impact factor: 3.857

5.  BRCA1 through Its E3 Ligase Activity Regulates the Transcription Factor Oct1 and Carbohydrate Metabolism.

Authors:  Karina Vázquez-Arreguín; Jessica Maddox; Jinsuk Kang; Dongju Park; Reuben R Cano; Rachel E Factor; Thomas Ludwig; Dean Tantin
Journal:  Mol Cancer Res       Date:  2018-01-12       Impact factor: 5.852

6.  HLA-C Level Is Regulated by a Polymorphic Oct1 Binding Site in the HLA-C Promoter Region.

Authors:  Nicolas Vince; Hongchuan Li; Veron Ramsuran; Vivek Naranbhai; Fuh-Mei Duh; Benjamin P Fairfax; Bahara Saleh; Julian C Knight; Stephen K Anderson; Mary Carrington
Journal:  Am J Hum Genet       Date:  2016-11-03       Impact factor: 11.025

7.  Pterostilbene leads to DNMT3B-mediated DNA methylation and silencing of OCT1-targeted oncogenes in breast cancer cells.

Authors:  Megan Beetch; Cayla Boycott; Sadaf Harandi-Zadeh; Tony Yang; Benjamin J E Martin; Thomas Dixon-McDougall; Kevin Ren; Allison Gacad; John H Dupuis; Melissa Ullmer; Katarzyna Lubecka; Rickey Y Yada; Carolyn J Brown; LeAnn J Howe; Barbara Stefanska
Journal:  J Nutr Biochem       Date:  2021-07-07       Impact factor: 6.048

8.  DNMT1 and DNMT3B gene variants and their association with endometriosis in South Indian women.

Authors:  K V Veena; Swapna Siddamalla; Mamata Deenadayal; Sisinthy Shivaji; Manjula Bhanoori
Journal:  Mol Biol Rep       Date:  2021-10-25       Impact factor: 2.316

9.  POU2F1 Promotes Cell Viability and Tumor Growth in Gastric Cancer through Transcriptional Activation of lncRNA TTC3-AS1.

Authors:  Jixu Wang; Ke Xiao; Futao Hou; Lusheng Tang; Dan Luo; Gu Liu; Zhiqiang Wang
Journal:  J Oncol       Date:  2021-06-28       Impact factor: 4.375

Review 10.  Immunoglobulin germline gene variation and its impact on human disease.

Authors:  Ivana Mikocziova; Victor Greiff; Ludvig M Sollid
Journal:  Genes Immun       Date:  2021-06-26       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.